AB0329 Clinical effectiveness and infection rate in rheumatoid arthritis patients switched from anti-tnf agents to abatacept

Background Increased risk of infection is an important safety concern in Rheumatoid Arthritis (RA) patients receiving biological therapies. Previous reports suggest a more favourable safety profile for Abatacept (ABT) respect to anti TNF. Objectives The aim of our study is to compare the incidence o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the rheumatic diseases 2013-06, Vol.72 (Suppl 3), p.A888-A888
Hauptverfasser:	Pietrosanti, M., Di Rosa, R., Salemi, S., Markovic, M., Carusi, V., Biondo, M. I., Catoni, M., Laganà, B., Sorgi, M. L., D’Amelio, R.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!